|Minimum Order Quantity||1 Bottle|
|Country of Origin||Made in India|
|Packing size||100 /21 Capsule|
POMALYST (Pomalidomide 1mg 2mg 4mg )is a prescription medicine used to treat adults with:
Multiple myeloma. Pomalyst is taken along with the medicine dexamethasone, in people who:have received at least 2 prior medicines to treat multiple myeloma, including a type of medicine known as a proteasome inhibitor and lenalidomide, andtheir disease has become worse during treatment or within 60 days of finishing the last treatmentAIDS-related Kaposi sarcoma (KS). Pomalyst is taken when highly active antiretroviral therapy (HAART) has not worked well enough or stopped working (failed)KS who do not have HIV infection (HIV negative).It is not known if Pomalyst is safe and effective in children.
Who should not take Pomalyst?
Do not take Pomalyst if you:
are pregnant, plan to become pregnant, or become pregnant during treatment with Pomalyst. See “What is the most important information I should know about Pomalyst?”are allergic to pomalidomide or any of the ingredients in Pomalyst. See the end of this Medication Guide for a complete list of ingredients in Pomalyst.What are the possible side effects of Pomalyst?
Pomalyst can cause serious side effects, including:
Low white blood cells (neutropenia), low platelets (thrombocytopenia), and low red blood cells (anemia) arecommon with Pomalyst, but can also be serious. You may need a blood transfusion or certain medicines if your blood counts drop too low. Your blood counts should be checked weekly for the first 8 weeks of treatment and monthly after that.Severe liver problems, including liver failure and death. Your healthcare provider should do blood tests to check your liver function during your treatment with Pomalyst. Tell your healthcare provider right away if you develop any of the following symptoms of liver problems:Yellowing of your skin or the white part of your eyes (jaundice)Dark or brown (tea-colored) urinePain on the upper right side of your stomach area (abdomen)Bleeding or bruising more easily than normalFeeling very tiredSevere allergic reactions and severe skin reactions can happen with Pomalyst and may cause death.Call your healthcare provider if you develop any of the following signs or symptoms during treatment with Pomalyst:
a red, itchy, skin rashpeeling of your skin or blisterssevere itchingfeverGet emergency medical help right away if you develop any of the following signs or symptoms during treatment with Pomalyst:
swelling of your lips, mouth, tongue, or throattrouble breathing or swallowingraised red areas on your skin (hives)a very fast heartbeatyou feel dizzy or faintDizziness and confusion. See “What should I avoid while taking Pomalyst?Nerve damage. Stop taking Pomalyst and call your healthcare provider if you develop symptoms of nerve damage including: numbness, tingling, pain, burning sensation in your hands, legs, or feet.Risk of new cancers (malignancies). New cancers, including certain blood cancers (acute myelogenous leukemia or AML) have been seen in people who received Pomalyst. Talk with your healthcare provider about your risk of developing new cancers if you take Pomalyst.Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your healthcare provider may do blood tests to check you for TLS.Your healthcare provider may tell you to stop taking Pomalyst if you develop certain serious side effects during treatment.
The most common side effects of Pomalyst in people with Multiple Myeloma include:
tiredness and weaknessconstipationnauseadiarrheashortness of breathupper respiratory tract infectionback painfever
- Production Capacity: NA
- Delivery Time: Immediate
- Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them.
Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to Trademark shown are property of their respective owners and we do not lay any claim on them.
Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory.
On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.